0001209191-23-009748.txt : 20230215
0001209191-23-009748.hdr.sgml : 20230215
20230215163040
ACCESSION NUMBER: 0001209191-23-009748
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230213
FILED AS OF DATE: 20230215
DATE AS OF CHANGE: 20230215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schwartz Eric
CENTRAL INDEX KEY: 0001329100
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26224
FILM NUMBER: 23635779
MAIL ADDRESS:
STREET 1: C/O ERESEARCHTECHNOLOGY, INC.
STREET 2: 1818 MARKET STREET, SUITE 1000
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP
CENTRAL INDEX KEY: 0000917520
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 510317849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1100 CAMPUS ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 6092750500
MAIL ADDRESS:
STREET 1: 1100 CAMPUS ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP
DATE OF NAME CHANGE: 19950614
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-13
0
0000917520
INTEGRA LIFESCIENCES HOLDINGS CORP
IART
0001329100
Schwartz Eric
1100 CAMPUS ROAD
PRINCETON
NJ
08540
0
1
0
0
EVP, Chief Legal Officer & Sec
Common Stock
2023-02-13
4
A
0
2156
0.00
A
39551
D
Common Stock
2023-02-13
4
A
0
560
0.00
A
40111
D
Common Stock
2023-02-13
4
A
0
1400
0.00
A
41511
D
Common Stock
2023-02-13
4
A
0
5641
0.00
A
47152
D
On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date.
On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date.
On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date.
/s/ Eric Schwartz
2023-02-15